Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molloy, P. T.
Right arrow Articles by Phillips, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molloy, P. T.
Right arrow Articles by Phillips, P. C.
NEUROLOGY 1995;45:1897-1902
© 1995 American Academy of Neurology

Brainstem tumors in patients with neurofibromatosis type 1

A distinct clinical entity

P. T. Molloy, MD, L. T. Bilaniuk, MD, S.N. Vaughan, RN, BSN, M. N. Needle, MD, G. T. Liu, MD, E. H. Zackai, MD and P. C. Phillips, MD

From the Divisions of Neurology (Drs. Molloy, Needle, and Phillips, and S.N. Vaughan), Oncology (Drs. Molloy, Needle, and Phillips), Radiology (Dr. Bilaniuk), Neuro-Ophthalmology (Dr. Liu), and Genetics (Dr. Zackai), The Children's Hospital of Philadelphia, PA.
Received October 24, 1994. Accepted in final form March 6, 1995.
Address correspondence and reprint requests to Dr. Patricia T. Molloy, Division of Neurology, The Children's Hospital of Philadelphia, 324 South 34th Street, Philadelphia, PA 19104.

The natural history and the clinical and neuroimaging features of brainstem tumors in neurofibromatosis type 1 (NF1) are poorly understood.Magnetic resonance imaging (MRI) has been useful in NF1 in detecting intracranial abnormalities, especially of the brainstem. Brainstem tumors in NF1 have been confused clinically with non-NF1 brainstem tumors and radiographically with the increased T2 signal abnormalities, also known as "unidentified bright objects" (UBOs), which are common in NF1 and often located in the brainstem. This study, which evaluated 17 NF1 patients with brainstem tumors, is the largest series to date. Fifteen of 17 patients (88%) had neurologic signs and symptoms referable to brainstem dysfunction, including dysarthria, cranial neuropathies, and gross motor incoordination. Tumors were located primarily in the medulla in 14 of 17 NF1 patients (82%), in contrast to the pontine tumor location in the non-NF1 population. Seven NF1 patients (41%) required shunt placement for hydrocephalus at initial diagnosis, more frequent than in non-NF1 brainstem tumor patients. Six of 17 patients (35%) had evidence of radiographic tumor progression, but only three of them (18%) had correlative clinical progression. Two patients with progressive symptoms had partial surgical resection, and pathology revealed either fibrillary or anaplastic astrocytomas. Three patients were treated with radiation therapy, chemotherapy, or both, with two deaths. With a median follow-up of 52 months, 15 of 17 patients remain alive; 14 of them did not require adjuvant therapy. In our series, we describe NF1 brainstem tumors as a distinct clinical entity, much less aggressive than non-NF1 pontine tumors but more symptomatic than brainstem UBOs in NF1.

NEUROLOGY 1995;45: 1897-1902




This article has been cited by other articles:


Home page
 NeurologyHome page
J. R. Leonard, A. Perry, J. B. Rubin, A. A. King, M. R. Chicoine, and D. H. Gutmann
The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1
Neurology, October 24, 2006; 67(8): 1509 - 1512.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. Theos and B. R. Korf
Pathophysiology of neurofibromatosis type 1.
Ann Intern Med, June 6, 2006; 144(11): 842 - 849.
[Full Text] [PDF]

Home page
 The OncologistHome page
J. T. Grier and T. Batchelor
Low-grade gliomas in adults.
Oncologist, June 1, 2006; 11(6): 681 - 693.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. S. Donaldson, F. Laningham, and P. G. Fisher
Advances Toward an Understanding of Brainstem Gliomas
J. Clin. Oncol., March 10, 2006; 24(8): 1266 - 1272.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. Broniscer and A. Gajjar
Supratentorial High-Grade Astrocytoma and Diffuse Brainstem Glioma: Two Challenges for the Pediatric Oncologist
Oncologist, April 1, 2004; 9(2): 197 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
K. Tada, M. Kochi, H. Saya, J.-i. Kuratsu, S. Shiraishi, T. Kamiryo, N. Shinojima, and Y. Ushio
Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1
Neuro-oncol, October 1, 2003; 5(4): 228 - 234.
[Abstract] [PDF]

Home page
 NeurologyHome page
D. H. Gutmann, S. A. Rasmussen, P. Wolkenstein, M. M. MacCollin, A. Guha, P. D. Inskip, K. N. North, M. Poyhonen, P. H. Birch, and J. M. Friedman
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1)
Neurology, September 10, 2002; 59(5): 759 - 761.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
D. H. Gutmann
Review Article : Neurofibromin in the Brain
J Child Neurol, August 1, 2002; 17(8): 592 - 601.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
T. Rosser and R. J. Packer
Review Article : Intracranial Neoplasms in Children With Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 630 - 637.
[Abstract] [PDF]

Home page
 JCOHome page
S. Gururangan, C. M. Cavazos, D. Ashley, J. E. Herndon II, C. S. Bruggers, A. Moghrabi, D. L. Scarcella, M. Watral, S. Tourt-Uhlig, D. Reardon, et al.
Phase II Study of Carboplatin in Children With Progressive Low-Grade Gliomas
J. Clin. Oncol., July 1, 2002; 20(13): 2951 - 2958.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J.-S. Guillamo, A. Creange, C. Kalifa, J. Grill, D. Rodriguez, F. Doz, S. Barbarot, M. Zerah, M. Sanson, S. Bastuji-Garin, et al.
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients
Brain, January 1, 2002; 126(1): 152 - 160.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J.-S. Guillamo, A. Monjour, L. Taillandier, B. Devaux, P. Varlet, C. Haie-Meder, G.-L. Defer, P. Maison, J.-J. Mazeron, P. Cornu, et al.
Brainstem gliomas in adults: prognostic factors and classification
Brain, December 1, 2001; 124(12): 2528 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
B. R. Korf
Malignancy in Neurofibromatosis Type 1
Oncologist, December 1, 2000; 5(6): 477 - 485.
[Abstract] [Full Text]

Home page
 Arch NeurolHome page
F. J. DiMario Jr, G. R. Ramsby, and J. A. Burleson
Brain Morphometric Analysis in Neurofibromatosis 1
Arch Neurol, November 1, 1999; 56(11): 1343 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. D. Griffiths, F. PhD, S. Blaser, W. Mukonoweshuro, D. Armstrong, G. Milo-Manson, and S. Cheung
Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential?
Pediatrics, October 1, 1999; 104(4): 49e - 49.
[Abstract] [Full Text]

Home page
 Am. J. Neuroradiol.Home page
O. Gonen, Z. J. Wang, A. K. Viswanathan, P. T. Molloy, and R. A. Zimmerman
Three-Dimensional Multivoxel Proton MR Spectroscopy of the Brain in Children with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1333 - 1341.
[Abstract] [Full Text]

Home page
 Arch NeurolHome page
F. J. DiMario Jr and G. Ramsby
Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1
Arch Neurol, April 1, 1998; 55(4): 500 - 505.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.